Mission and Goals

The mission of the NCI’s Office of Cancer Genomics (OCG) is to enhance understanding of the molecular mechanisms of cancer, with the ultimate goal of improving the prevention, early detection, diagnosis, and treatment of cancer. Learn More

OCG Programs


The Cancer Genome Anatomy Project (CGAP)
CGAP is an online resource designed to characterize biological tissues and provide cDNA clones to the research community....more


The NIH Mammalian Gene Collection (MGC)
The goal of MGC is to provide full-length open reading frame (FL-ORF) clones for human, mouse, and rat genes....more


The Initiative for Chemical Genetics (ICG)
The ICG provides a systematic approach to study biology using such small molecules, to develop new screening tools and compounds, and to accelerate the development of new cancer strategies and therapies....more


The Cancer Genome Atlas (TCGA)
TCGA is a collaborative effort between the NCI and the NHGRI that will test the feasibility of a large-scale systematic approach to identify genetic alterations in human cancer....more


Cancer Genetic Markers of Susceptibility (CGEMS)
CGEMS is an NCI enterprise initiative to conduct whole-genome association studies to identify genes giving rise to risk of prostate and breast cancer....more


Therapeutically Applicable Research to Generate Effective Treatments (TARGET)
The TARGET Initiative seeks to harness the power of modern genomics technologies to rapidly identify valid therapeutic targets in childhood cancers so that new, more effective treatments can be developed....more


For more information about funding available through the Office of Cancer Genomics, click here.

Sign Up

Enter your email address below to sign up to receive updates from ocg.cancer.gov.